Issue 1/2012
Content (26 Articles)
Cell phones and glioma risk: a review of the evidence
Courtney Corle, Milan Makale, Santosh Kesari
Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review
Elena Pentsova, Anli Liu, Marc Rosenblum, Eileen O’Reilly, Xi Chen, Adília Hormigo
Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis
Zinovia Kefalopoulou, Vassiliki Tzelepi, Vassiliki Zolota, Petros D. Grivas, Christos Christopoulos, Haralabos Kalofonos, Theodoros Maraziotis, Georgia Sotiropoulou-Bonikou
MGMT expression and promoter methylation status may depend on the site of surgical sample collection within glioblastoma: a possible pitfall in stratification of patients?
Alessandro Della Puppa, Luca Persano, Giulia Masi, Elena Rampazzo, Alessandro Sinigaglia, Francesca Pistollato, Luca Denaro, Luisa Barzon, Giorgio Palù, Giuseppe Basso, Renato Scienza, Domenico d’Avella
Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas
Xiao-bing Wang, Xiao-ying Tian, Yang Li, Bin Li, Zhi Li
The genotoxic effect of radiofrequency waves on mouse brain
Emin Karaca, Burak Durmaz, Huseyin Altug, Teoman Yildiz, Candan Guducu, Melis Irgi, Mehtap Gulcihan Cinar Koksal, Ferda Ozkinay, Cumhur Gunduz, Ozgur Cogulu
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling
Flora Cimmino, Maria Nunzia Scoppettuolo, Marianeve Carotenuto, Pasqualino De Antonellis, Valeria Di Dato, Gennaro De Vita, Massimo Zollo
Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma
Carolina Oliveira Rodini, Daniela Emi Suzuki, Najsla Saba-Silva, Andréa Cappellano, Jorge Estefano Santana de Souza, Sérgio Cavalheiro, Silvia Regina Caminada Toledo, Oswaldo Keith Okamoto
The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis
Priscilla K. Brastianos, Harry C. Brastianos, Wesley Hsu, Daniel M. Sciubba, Thomas Kosztowski, Betty M. Tyler, Violette Renard Recinos, Peter Burger, Stuart A. Grossman
Growth-inhibitory effect of neurotrophin-3-secreting adipose tissue-derived mesenchymal stem cells on the D283-MED human medulloblastoma cell line
Young-Hoon Kim, Seung Hee Cho, Soo Jung Lee, Seung Ah Choi, Ji Hoon Phi, Seung-Ki Kim, Kyu-Chang Wang, Byung-Kyu Cho, Chae-Yong Kim
The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway
Gangadhara Reddy Sareddy, Khamushavalli Geeviman, Chinta Ramulu, Phanithi Prakash Babu
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab
Benjamin M. Ellingson, Timothy F. Cloughesy, Albert Lai, Phioanh L. Nghiemphu, Shadi Lalezari, Taryar Zaw, Kourosh Motevalibashinaeini, Paul S. Mischel, Whitney B. Pope
Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients
Andrew D. Norden, Julia Bartolomeo, Shota Tanaka, Jan Drappatz, Abigail S. Ciampa, Lisa M. Doherty, Debra C. LaFrankie, Sandra Ruland, Eudocia C. Quant, Rameen Beroukhim, Patrick Y. Wen
Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression
Nadia Malkoun, Cyrus Chargari, Fabien Forest, Marie-Jeannette Fotso, Lysian Cartier, Pierre Auberdiac, Julie Thorin, Cécile Pacaut, Michel Peoc’h, Christophe Nuti, Thierry Schmitt, Nicolas Magné
p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease
Marco Gessi, André O. von Bueren, Stefan Rutkowski, Torsten Pietsch
Prophylactic intrathecal chemotherapy in primary CNS lymphoma
Monica Sierra del Rio, Damien Ricard, Caroline Houillier, Soledad Navarro, Alberto Gonzalez-Aguilar, Ahmed Idbaih, Gentian Kaloshi, Soufiane Elhallani, Antonio Omuro, Sylvain Choquet, Carole Soussain, Khé Hoang-Xuan
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
Mark R. Gilbert, John Kuhn, Kathleen R. Lamborn, Frank Lieberman, Patrick Y. Wen, Minesh Mehta, Timothy Cloughesy, Andrew B. Lassman, Lisa M. DeAngelis, Susan Chang, Michael Prados
Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status
Keishi Makino, Hideo Nakamura, Taku-ichiro Hide, Jun-ichi Kuratsu
Progression of the lung cancer primary correlates with the identification of new brain metastases after initial radiosurgery
Jung Ho Han, Dong Gyu Kim, Chang Wan Oh, Chae-Yong Kim, Young Hoon Kim, Jeong Hoon Park, Eun Kyung Kim, Hee-Won Jung
Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment
Romuald Le Scodan, Christophe Massard, Ludivine Jouanneau, Florence Coussy, Maya Gutierrez, Youlia Kirova, Florence Lerebours, Alain Labib, Emmanuelle Mouret-Fourme
Modification of loco-regional microenvironment in brain tumors by spinal cord stimulation. Implications for radio-chemotherapy
B. Clavo, F. Robaina, B. Valcarcel, L. Catala, J. L. Perez, A. Cabezon, I. J. Jorge, D. Fiuza, M. A. Hernandez, R. Jover, J. L. Carreras
Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review
Alan A. Moazzam, Jan Drappatz, Ryan Y. Kim, Santosh Kesari
Gangliocytoma of the medulla oblongata demonstrating high tracer uptake on positron emission tomography
Ryuji Awa, Ryosuke Hanaya, Hirofumi Hirano, Campos Francia, Shinichi Kitajima, Kazunori Arita
Subcutaneous malignant melanoma of the scalp surgical flap after brain irradiation for anaplastic astrocytoma
Carmelo Lucio Sturiale, Giovanni Sabatino, Alessio Albanese, Mario Balducci, Libero Lauriola, Ilaria Pennacchia, Giulio Maira
Intravenous administration of temozolomide as a useful alternative over oral treatment with temozolomide capsules in patients with gliomas
Kazuya Motomura, Atsushi Natsume, Toshihiko Wakabayashi
A new tool for grade II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation
Emmanuel Mandonnet, Hugues Duffau, Luc Bauchet